Loading…
Loading…
EQUITY / NYSE · XNYS
Dr. Reddy's Laboratories Ltd. ADR
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2024 – 03/31/2025 · INR · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗12.29 USD · -1.6013%
Observed: Oct 7, 2026, 9:12 AM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/06/2026 · 12.49 USD · Volume 3,998,614
680 actual observations · Latest bar: 2026-10-06 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2024 – 03/31/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Revenue | 325,535,000,000 INR | 279,164,000,000 INR | +16.61% |
| Operating profit | 71,843,000,000 INR | 67,729,000,000 INR | +6.07% |
| Net income | 57,245,000,000 INR | 55,684,000,000 INR | +2.80% |
| Operating cash flow | 46,428,000,000 INR | 45,433,000,000 INR | +2.19% |
| Cash and cash equivalents | 14,654,000,000 INR | 7,107,000,000 INR | +106.19% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end04/01/2024 – 03/31/2025ConsolidatedUnits · INR | 2024 / Year end04/01/2023 – 03/31/2024ConsolidatedUnits · INR | 2023 / Year end04/01/2022 – 03/31/2023ConsolidatedUnits · INR |
|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 14,654,000,000 INR | 7,107,000,000 INR | — |
| Financing cash flowCash flow statement | 18,911,000,000 INR | -3,763,000,000 INR | -26,861,000,000 INR |
| Gross profitIncome statement | 190,428,000,000 INR | 163,607,000,000 INR | 139,343,000,000 INR |
| Investing cash flowCash flow statement | -58,077,000,000 INR | -40,283,000,000 INR | -41,373,000,000 INR |
| Net incomeIncome statement | 57,245,000,000 INR | 55,684,000,000 INR | 45,067,000,000 INR |
| Operating cash flowCash flow statement | 46,428,000,000 INR | 45,433,000,000 INR | 58,875,000,000 INR |
| Operating profitIncome statement | 71,843,000,000 INR | 67,729,000,000 INR | 57,144,000,000 INR |
| RevenueIncome statement | 325,535,000,000 INR | 279,164,000,000 INR | 245,879,000,000 INR |
| Total assetsBalance sheet | 492,989,000,000 INR | 387,518,000,000 INR | — |
| Total equityBalance sheet | 337,166,000,000 INR | 280,550,000,000 INR | 230,991,000,000 INR |
| Total liabilitiesBalance sheet | 155,823,000,000 INR | 106,968,000,000 INR | — |
| Report source | Open report ↗ Published: 06/06/2025 | Open report ↗ Published: 06/06/2025 | Open report ↗ Published: 06/06/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.